(Q44603419)

4 December 2017

title

Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex (English)

1 reference

4 December 2017

0 references

1 reference

4

Deborah R Medoff

1 reference

4 December 2017

7

Carol A Tamminga

1 reference

4 December 2017

Adrienne C Lahti

1

1 reference

4 December 2017

Henry H Holcomb

2

1 reference

4 December 2017

Martin A Weiler

3

1 reference

4 December 2017

Kristin N Frey

5

1 reference

4 December 2017

Michael Hardin

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

4 December 2017

published in

Neuropsychopharmacology

1 reference

4 December 2017

volume

29

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

171-178

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300312

4 December 2017

exact match

0 references

cites work

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Structural evaluation of the prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Cognitive and emotional influences in anterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Toward a brain map of auditory hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine-associated reduction in arrest rates of psychotic patients with criminal histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Detecting activations in PET and fMRI: levels of inference and power.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

A Neural System for Error Detection and Compensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Assessment of procedural learning and problem solving in schizophrenic patients by Tower of Hanoi type tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Initiating clozapine treatment in the outpatient clinic: service utilization and cost trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Problem solving in schizophrenia: a specific deficit in planning ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

A functional neuroanatomy of hallucinations in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Where the imaginal appears real: a positron emission tomography study of auditory hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

A three-dimensional statistical analysis for CBF activation studies in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Mapping Auditory Hallucinations in Schizophrenia Using Functional Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

The contribution of the anterior cingulate cortex to executive processes in cognition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300312

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300312

1 reference

4 December 2017

1 reference